Gene · 3675
Papers2,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer. | Front Cell Dev Biol | 2023 | 37457288 | PubTator, text mining | PubMed |
| Focal-adhesion kinase regulates the sialylation of N-glycans via the PI4KIIα-PI4P pathway. | J Biol Chem | 2023 | 37451482 | PubTator, text mining | PubMed |
| A prognostic biomarker NRG1 promotes U-87 MG glioblastoma cell malignancy by inhibiting autophagy via ERBB2/AKT/mTOR pathway. | J Cell Biochem | 2023 | 37450666 | PubTator, text mining | PubMed |
| Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development. | Int J Mol Sci | 2023 | 37445641 | PubTator, text mining | PubMed |
| The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment. | Cancers (Basel) | 2023 | 37444578 | PubTator, text mining | PubMed |
| Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology. | Cancers (Basel) | 2023 | 37444576 | PubTator, text mining | PubMed |
| Skeletal muscle integrin expression in non-obese men with varying degrees of insulin sensitivity. | Endocr J | 2023 | 37438145 | PubTator, text mining | PubMed |
| AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37435231 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer. | Cell Commun Signal | 2023 | 37430270 | PubTator, text mining | PubMed |
| An information theoretic approach to detecting spatially varying genes. | Cell Rep Methods | 2023 | 37426750 | PubTator, text mining | PubMed |
| The Upscale Manufacture of Chondrocytes for Allogeneic Cartilage Therapies. | Tissue Eng Part C Methods | 2023 | 37395490 | PubTator, text mining | PubMed |
| SnRNA-Seq analysis reveals ten hub genes associated with alveolar epithelial cell injury during pulmonary acute respiratory distress syndrome. | Heliyon | 2023 | 37389073 | PubTator, text mining | PubMed |
| Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion. | Cell Stem Cell | 2023 | 37385251 | PubTator, text mining | PubMed |
| The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation. | Front Oncol | 2023 | 37377917 | PubTator, text mining | PubMed |
| Partner, Neighbor, Housekeeper and Dimension: 3D versus 2D Glomerular Co-Cultures Reveal Drawbacks of Currently Used Cell Culture Models. | Int J Mol Sci | 2023 | 37373531 | PubTator, text mining | PubMed |
| High Rate of Mutations of Adhesion Molecules and Extracellular Matrix Glycoproteins in Patients with Adult-Onset Focal and Segmental Glomerulosclerosis. | Biomedicines | 2023 | 37371859 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in the Pathogenesis of Hematological Malignancies: Interaction with Tumor Microenvironment; a Potential Biomarker and Targeted Therapy. | Biomolecules | 2023 | 37371477 | PubTator, text mining | PubMed |
| ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC. | Cell Mol Gastroenterol Hepatol | 2023 | 37331567 | PubTator, text mining | PubMed |
| Histone Modification of Osteogenesis Related Genes Triggered by Substrate Topography Promotes Human Mesenchymal Stem Cell Differentiation. | ACS Appl Mater Interfaces | 2023 | 37310722 | PubTator, text mining | PubMed |
| A Peptidisc-Based Survey of the Plasma Membrane Proteome of a Mammalian Cell. | Mol Cell Proteomics | 2023 | 37295717 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3675/papers?page=16